Publications Database

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

Buitelaar J. K. , van der Gaag R. J. , van der Hoeven J. (1998)

Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study.

Journal of Clinical Psychiatry

59(2), pp. 56-59

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Fayyazi A. et al. (2014)

A comparison of risperidone and buspirone for treatment of behavior disorders in children with phenylketonuria.

Iranian Journal of Child Neurology

Fall, 8(4), pp. 33-38.

Read Abstract (New Window) Read Full (New Window)

Fink M. , Taylor M. A. , Ghaziuddin N. (2006)

Catatonia in autistic spectrum disorders: a medical treatment algorithm.

International Review of Neurobiology

72 pp. 233-244

Read Abstract (New Window)

Jobski K. et al. (2016)

Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.

Acta Psychiatrica Scandinavica

pp. 1-21.

Read Abstract (New Window)

Mandell D. S. et al. (2008)

Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders.

Pediatrics

121(3), e441-e448

Read Abstract (New Window) Read Full (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Oswald D. P. , Sonenklar N. A. (2007)

Medication use among children with autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

17(3), pp. 348-355

Read Abstract (New Window)

American Society of Health-System Pharmacists (2011)

Buspirone.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2010)

Lorazepam.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Realmuto G. , August G. , Garfinkel B. (1989)

Clinical effect of buspirone in autistic children.

Journal of Clinical Psychopharmacology

9(2), pp. 122-125

Read Abstract (New Window)

Riddle M. A. et al. (1999)

Anxiolytics, adrenergic agents, and naltrexone.

Journal of the American Academy of Child and Adolescent Psychiatry

38(5), pp. 546-556

Read Abstract (New Window)

Sharma A. , Shaw S. R. (2012)

Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis.

Journal of Pediatric Health Care

264(4), pp. 291-299.

Read Abstract (New Window)

Taylor L. J. (2016)

Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review.

Research in Autism Spectrum Disorders

25 pp. 58-75.

Read Abstract (New Window)

Vasa R. A. et al. (2014)

A systematic review of treatments for anxiety in youth with autism spectrum disorders.

Journal of Autism and Developmental Disorders

December, 44(12), pp. 3215-3229.

Read Abstract (New Window)

Wachtel L. E. et al. (2010)

Brief report: Electroconvulsive therapy for malignant catatonia in an autistic adolescent.

Autism

14(4), pp. 349-358

Read Abstract (New Window)

Wachtel L. E. et al. (2008)

ECT for catatonia in an autistic girl.

American Journal of Psychiatry

165(3), pp. 329-333

Read Full (New Window)